Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the coronary artery disease market grown over the years?

The market size for coronary artery disease has seen considerable growth in the past years. Projected growth includes a rise from $29.15 billion in 2024 to $31.97 billion in 2025, representing a compound annual growth rate (CAGR) of 9.7%. The historic period’s growth can be credited to factors such as the increased prevalence of coronary artery disease, the escalation in minimally invasive surgeries, the rise in sedentary lifestyles, the aging population and cad prevalence, along with the development of pharmacological treatments.

What Is the forecasted market size and growth rate for the coronary artery disease market?

The market size of coronary artery disease is predicted to experience swift expansion in the subsequent years, surging to $48.48 billion in 2029, with a compound annual growth rate of 11.0%. This acceleration within the prediction phase can be linked to various factors such as alterations in lifestyle, emphasis on telemedicine and distant observation, scaling up of interventional cardiology practices, transition towards value-oriented healthcare arrangements, and the innovation of new medication therapies. The forecast period is expected to witness key trends like the advent of gene therapies, uptake of artificial intelligence in diagnoses, attention towards mental health in CAD management, increase in at-home healthcare amenities, and the embrace of distanced cardiac rehabilitation.

Get your coronary artery disease market report here!

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

What are the major factors driving growth in the coronary artery disease market?

The coronary artery disease market is anticipated to surge in growth due to the increasing prevalence of the disease. Characterized by the narrowing or blockage of blood-supplying coronary arteries, coronary artery disease (CAD) cases are climbing due to factors such as changes in diet, stress levels, insufficient exercise, obesity, age, and more. Treatments for CAD comprise medications such as clopidogrel, ticagrelor, warfarin, and heparin, as well as medical procedures like coronary artery bypass grafting, angioplasty, and stenting. Data from the Centre of Disease Control and Prevention, a U.S.-based federal agency within the U.S. Department of Health and Human Services, showed in May 2024 that coronary heart disease (CHD) was the primary form of heart disease, causing 371,506 deaths in 2022. Additionally, around 5% of adults aged 20 and older (1 in 20) were diagnosed with coronary artery disease (CAD). In 2022, nearly 1 in 5 cardiovascular disease (CVD) deaths were recorded in adults younger than 65 years old. Thus, the growing prevalence of coronary artery disease is likely to fuel the growth of the coronary artery disease market in the forthcoming years.

What key areas define the segmentation of the global coronary artery disease Market?

The coronary artery disease market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications

2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions

3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

What are the top market players propelling the growth of the coronary artery disease industry?

Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

What are the key trends shaping the future of the coronary artery disease market?

Leading firms in the coronary artery disease market are emphasizing the development of advanced technology, including AI-infused blood tests, to strengthen their competitive stand. An AI-integrated blood test embodies a diagnostic examination that utilizes artificial intelligence algorithms to analyze and interpret blood-related information. In February 2023, for instance, Cardio Diagnostics Holdings, an American company specializing in AI-based integrated genetic-epigenetic engine production, introduced PrecisionCHD. This is a combined genetic and epigenetic blood test, developed for early detection of coronary heart disease. PrecisionCHD shows more than 75% sensitivity in detecting coronary heart disease among both genders. The test employs a machine-learning model that traces its fundamentals to the examination of billions of genomic and epigenomic data elements, combining epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052

What regions are dominating the coronary artery disease market growth?

North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Automotive Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-repair-and-maintenance-global-market-report

Electric Motor And Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

Automotive Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-cables-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: